NAT2 and urinary bladder carcinoma: Rothman et al. also identified the interactions between the GSTM1 deletion and a tag SNP for NAT2 acetylation status and bladder cancer risk4, which suggested that bladder cancer susceptibility loci participated in tumorigenesis by complex combination of genetic and environmental factors.